TY - JOUR
T1 - Primary Sclerosing Cholangitis
AU - Brennan, F.
AU - O'connor, F. A.
AU - Larusso, Nicholas F.
AU - Wiesner, Russell H.
AU - Ludwig, Jurgen
AU - Maccarty, Robert
PY - 1984/8/2
Y1 - 1984/8/2
N2 - To the Editor: We recently reviewed the literature on primary sclerosing cholangitis while studying four cases diagnosed here since 1973. LaRusso et al. state that the course of the disease is generally one of slow progression to cirrhosis, portal hypertension, and death from liver failure, though the time course is unpredictable (April 5 issue).1 The incidence of sclerosing cholangitis has increased by up to 100 per cent in many institutions since the introduction of endoscopic retrograde cholangiopancreatography.2,3 Also, in two populations of patients with ulcerative colitis who were screened for hepatobiliary disease, the incidence of sclerosing cholangitis was put at.
AB - To the Editor: We recently reviewed the literature on primary sclerosing cholangitis while studying four cases diagnosed here since 1973. LaRusso et al. state that the course of the disease is generally one of slow progression to cirrhosis, portal hypertension, and death from liver failure, though the time course is unpredictable (April 5 issue).1 The incidence of sclerosing cholangitis has increased by up to 100 per cent in many institutions since the introduction of endoscopic retrograde cholangiopancreatography.2,3 Also, in two populations of patients with ulcerative colitis who were screened for hepatobiliary disease, the incidence of sclerosing cholangitis was put at.
UR - http://www.scopus.com/inward/record.url?scp=0021269015&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0021269015&partnerID=8YFLogxK
U2 - 10.1056/NEJM198408023110515
DO - 10.1056/NEJM198408023110515
M3 - Letter
C2 - 6738646
AN - SCOPUS:0021269015
SN - 0028-4793
VL - 311
SP - 331
JO - New England Journal of Medicine
JF - New England Journal of Medicine
IS - 5
ER -